Clinical Trial: A single-center, randomized, open-label, crossover, ramelteon tablet-controlled Phase I clinical study to evaluate the pharmacokinetic and safety profiles of a single oral dose of ramelteon dual-release tablets in Chinese healthy subjects (China)

China, Aug. 25 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'A single-center, randomized, open-label, crossover, ramelteon tablet-controlled Phase I clinical study to evaluate the pharmacokinetic and safety profiles of a single oral dose of ramelteon dual-release tablets in Chinese healthy subjects'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600130726

Registration Time: 2026/08/24

Type: Interventional study

Primary Sponsor: The Second Hospital of Anhui Medical University

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=331056

Published by HT Digital Content Services with permission from Health Daily Digest....